Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Zydus Lifesciences Limited ( (IN:ZYDUSLIFE) ).
Zydus Lifesciences Limited announced the closure of a USFDA surveillance inspection at its API Unit in Dabhasa, Gujarat, which took place from April 21 to April 25, 2025. The inspection resulted in six observations, none of which were related to Data Integrity, and the company is confident in addressing these observations promptly, indicating a proactive approach to maintaining compliance and quality standards.
More about Zydus Lifesciences Limited
Zydus Lifesciences Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products, including active pharmaceutical ingredients (APIs). The company is committed to providing high-quality healthcare solutions and has a significant market presence in both domestic and international markets.
YTD Price Performance: -9.63%
Average Trading Volume: 65,417
Current Market Cap: 885.3B INR
For detailed information about ZYDUSLIFE stock, go to TipRanks’ Stock Analysis page.